Cathelicidin antimicrobial protein, vitamin D, and risk of death in critically ill patients

INTRODUCTION: Decreased production of cathelicidin antimicrobial protein-18 (hCAP18) has been proposed to be a key mechanism linking decreased 25-hydroxyvitamin D (25D) levels with adverse outcomes among critically ill patients. However, few studies in humans have directly assessed plasma hCAP18 lev...

Descripción completa

Detalles Bibliográficos
Autores principales: Leaf, David E, Croy, Heather E, Abrahams, Sara J, Raed, Anas, Waikar, Sushrut S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357206/
https://www.ncbi.nlm.nih.gov/pubmed/25887571
http://dx.doi.org/10.1186/s13054-015-0812-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357206/
https://www.ncbi.nlm.nih.gov/pubmed/25887571
http://dx.doi.org/10.1186/s13054-015-0812-1

Ejemplares similares